Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
INTS
#3863
Intensity Therapeutics, Inc. Common stock
7.6
6
+4.64%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+4.64%
Monatliche Änderung
+1915.79%
6 month change
+2541.38%
Jahresänderung
+234.50%
Vorheriger Schlusskurs
7.3
2
Open
7.6
6
Bid
Ask
Low
7.6
6
High
7.6
6
Volumen
1
Märkte
Aktien
Gesundheitswesen
INTS
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2023
2024
TTM
Key stats
Total common shares outstanding
548.38 K
607.24 K
—
Valuation ratios
Enterprise value
-3.8 M
-1.52 M
-9.12 M
Price to earnings ratio
-0.25
-0.06
-0.17
Price to sales ratio
1.32
—
—
Price to cash flow ratio
0.41
0.06
0.18
Price to book ratio
0.23
0.34
0.47
Enterprise value to EBITDA ratio
—
—
—
Profitability ratios
Return on assets %
0.61
3.41
2.6
Return on equity %
0.8
5.59
12.51
Return on invested capital %
1 797.73
4 021.82
—
Gross margin %
100
—
—
Operating margin %
367.77
—
—
EBITDA margin %
—
—
—
Net margin %
464.19
—
—
Liquidity ratios
Quick ratio
—
—
—
Current ratio
3.91
1.92
7.54
Inventory turnover
—
—
—
Asset turnover
0.13
0
—
Solvency ratios
Debt to assets ratio
—
—
—
Debt to equity ratio
—
—
—
Long term debt to total assets ratio
—
—
—
Long term debt to total equity ratio
—
—
—
Per share metrics
Operating cash flow per share
20.91
27.36
12.71
EBIT per share
—
—
—
EBITDA per share
—
—
—
Total debt per share
—
—
—
Cash per share
42.94
4.67
13.2
Net current asset value per share
44.87
6.05
17.55
Tangible book value per share
38.19
5.25
12.88
Working capital per share
33.38
2.89
5.87
Book value per share
38.19
5.25
12.88
Nachrichten
Intensity Therapeutics kündigt Aktienzusammenlegung im Verhältnis 1:25 an
Intensity Therapeutics announces 1-for-25 reverse stock split
What's Going On With Intensity Therapeutics Stock Friday? - Intensity Therapeutics (NASDAQ:INTS)
Intensity Therapeutics legt nach klinischer Validierung Strategie für 2026 fest/n
Intensity therapeutics outlines 2026 priorities after clinical validation
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy
Intensity Therapeutics: Aktie steigt nach Fristverlängerung für NASDAQ-Listing
Intensity Therapeutics stock rises after securing Nasdaq listing extension
Intensity Therapeutics erhält 180-tägige Fristverlängerung zur Erfüllung der NASDAQ-Kursvorgabe
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule
Intensity Therapeutics erweitert Kapitalbeschaffungsprogramm auf 30 Millionen US-Dollar/n
Intensity Therapeutics expands at-the-market offering program to $30 million